Practical measurement of affordability: an application to medicines
LM Niëns, E Van de Poel, A Cameron, M Ewen, R Laing & WBF Brouwer
Volume 90, Number 3, March 2012, 219-227
Table 1. Percentage of population impoverished or at risk of incurring catastrophic expenditure by purchasing treatment with lowest-priced generic equivalent of glibenclamide, by micro method using micro data for India and Indonesia
|Country (source)||Population (%) below PL before medicine purchase (Ipre)
||Population (%) impoverished by medicine purchase (Ipost − Ipre)a
||Catastrophic expenditure (Xcat)b|
|< US$ 1.25c PL||< US$ 2.00c PL||< US$ 1.25c PL||< US$ 2.00c PL|
|Indonesia (WDI 2005)||28.8||61.7||5.8||3.7||65.9|
|India (WDI 2000)||53.0||80.4||5.1||1.9||78.6|
Ipost, percentage of the population below the poverty line (PL) after expenditure; Ipre, percentage of the population below the PL before expenditure; WDI, world development indicators (World Bank); Xcat, percentage of the population at risk of incurring a catastrophic expenditure at a threshold of 5% of per capita household expenditures.
a Impoverishment method.
b Catastrophic expenditure method.
c Purchasing power parity United States dollars (2005).